Image may be NSFW.
Clik here to view.
Shares in MannKind Corp. (NSDQ:MNKD) fell slightly this morning after the biopharmaceutical company missed earnings expectations but beat sales estimates on Wall Street with its second quarter results.
The Valencia, Calif.-based company posted a net loss of -$35.4 million on sales of $2.2 million for the 3 months ended June 30, for bottom-line loss of -18% on sales growth of 100% compared with the same period last year.
Get the full story at out sister site, Drug Delivery Business News.
The post MannKind posts mixed Q2 appeared first on MassDevice.
